LCDActive
Nerve Blocks and Electrostimulation for Peripheral Neuropathy
L37642
Effective: October 3, 2024
Updated: December 31, 2025
Policy Summary
Nerve blocks and electrostimulation (alone or combined) are considered investigational and are not covered for the treatment of neuropathies or peripheral neuropathies caused by underlying systemic diseases. Clinical management with systemic medications is the indicated treatment; the evidence base for these procedures in systemic-disease–related neuropathy is insufficient to warrant coverage.
Coverage Criteria Preview
Key requirements from the full policy
"Peripheral nerve blocks (with or without electrostimulation) and electrostimulation alone for treatment of neuropathies or peripheral neuropathies caused by underlying systemic diseases are conside..."
Sign up to see full coverage criteria, indications, and limitations.